RANDAL J. KIRK SC 13G 2-14-2014 (AMPLIPHI BIOSCIENCES CORPORATION)

Company

Armata Pharmaceuticals, Inc.

Filed

February 13, 2015

Accession Number

0001140361-15-006434

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →